Figure 1.
Simplified diagram of Markov model structure. (A) Treatment sequence for patients who receive third-line CAR T-cell therapy (axi-cel). (B) Treatment sequence for patients who receive third-line SOC therapies (immunochemotherapy, HSCT, lenalidomide with anti-CD20 monoclonal antibody, and anti-CD20 monoclonal antibody).

Simplified diagram of Markov model structure. (A) Treatment sequence for patients who receive third-line CAR T-cell therapy (axi-cel). (B) Treatment sequence for patients who receive third-line SOC therapies (immunochemotherapy, HSCT, lenalidomide with anti-CD20 monoclonal antibody, and anti-CD20 monoclonal antibody).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal